Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.051 | 0.7 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |